According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

On this World Cancer Day, Chris Vogelsang, a cancer survivor from upstate New York, is celebrating his recovery thanks to a ...

Stem cell therapy has come a long way since its early days. As an athlete who has undergone it twice, I know that the ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a ...

In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

A group of Penn scientists has developed a new method to remotely control engineered cells inside the human body using heat.

A study of 783 patients treated with CAR T cell therapy found no evidence that the therapy itself caused secondary cancers.